These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 10544915

  • 1. Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability.
    Kitchen S, Iampietro R, Woolley AM, Preston FE.
    Thromb Haemost; 1999 Oct; 82(4):1289-93. PubMed ID: 10544915
    [Abstract] [Full Text] [Related]

  • 2. Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay.
    Kitchen S, Theaker J, Preston FE.
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):137-44. PubMed ID: 10759006
    [Abstract] [Full Text] [Related]

  • 3. Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.
    Harenberg J, Haaf B, Dempfle CE, Stehle G, Heene DL.
    Nephrol Dial Transplant; 1995 Mar; 10(2):217-22. PubMed ID: 7753456
    [Abstract] [Full Text] [Related]

  • 4. A novel point-of-care assay for the monitoring of low-molecular weight heparins in the cardiac catheterization laboratory.
    Marmur JD, Lakhani M, El Rouby S, Cavusoglu E.
    J Invasive Cardiol; 2008 Sep; 20(9):449-54. PubMed ID: 18762674
    [Abstract] [Full Text] [Related]

  • 5. How useful is the monitoring of (low molecular weight) heparin therapy by anti-Xa assay? A laboratory perspective.
    Favaloro EJ, Bonar R, Aboud M, Low J, Sioufi J, Wheeler M, Lloyd J, Street A, Marsden K, RCPA QAP in Haematology.
    Lab Hematol; 2005 Sep; 11(3):157-62. PubMed ID: 16174600
    [Abstract] [Full Text] [Related]

  • 6. [Monitoring of plasma concentration of low molecular weight heparin--comparative evaluation with chromogenic and clotting assays].
    Katagiri H, Itoh S, Uchida T, Kawai Y, Watanabe K.
    Rinsho Byori; 1999 Nov; 47(11):1046-51. PubMed ID: 10590682
    [Abstract] [Full Text] [Related]

  • 7. Effect of tissue factor pathway inhibitor (TFPI) in the HEPTEST assay and in an amidolytic anti factor Xa assay for LMW heparin.
    Kristensen HI, Ostergaard PB, Nordfang O, Abildgaard U, Lindahl AK.
    Thromb Haemost; 1992 Sep 07; 68(3):310-4. PubMed ID: 1332210
    [Abstract] [Full Text] [Related]

  • 8. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P, Kuitunen A, Petäjä J, Ilveskero S, Lassila R.
    Thromb Haemost; 2008 Feb 07; 99(2):427-34. PubMed ID: 18278195
    [Abstract] [Full Text] [Related]

  • 9. A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers.
    Eriksson BI, Söderberg K, Widlund L, Wandeli B, Tengborn L, Risberg B.
    Thromb Haemost; 1995 Mar 07; 73(3):398-401. PubMed ID: 7667822
    [Abstract] [Full Text] [Related]

  • 10. [Biological monitoring of treatment with low molecular weight heparin].
    Aiach M, Sié P.
    Ann Biol Clin (Paris); 1988 Mar 07; 46(9):715-8. PubMed ID: 2851948
    [Abstract] [Full Text] [Related]

  • 11. Analysis of unfractionated heparin dose requirements to target therapeutic anti-Xa intensity during pregnancy.
    Clark NP, Delate T, Cleary SJ, Witt DM.
    Thromb Res; 2010 May 07; 125(5):402-5. PubMed ID: 19699510
    [Abstract] [Full Text] [Related]

  • 12. Variability of plasma anti-Xa activities with different lots of enoxaparin.
    Gosselin RC, King JH, Janatpour KA, Dager WE, Larkin EC, Owings JT.
    Ann Pharmacother; 2004 Apr 07; 38(4):563-8. PubMed ID: 14982983
    [Abstract] [Full Text] [Related]

  • 13. A new chronometric assay to determine plasma antifactor Xa activity which is insensitive to the antithrombin activity of low molecular weight heparins.
    Dignac M, Gabaig AM, Cambus JP, Boneu B.
    Nouv Rev Fr Hematol (1978); 1994 Apr 07; 35(6):545-9. PubMed ID: 8152901
    [Abstract] [Full Text] [Related]

  • 14. The correlation between plasma anti-factor Xa activity and haemostatic tests in healthy dogs, following the administration of a low molecular weight heparin.
    Mischke R, Grebe S.
    Res Vet Sci; 2000 Dec 07; 69(3):241-7. PubMed ID: 11124095
    [Abstract] [Full Text] [Related]

  • 15. Monitoring Unfractionated Heparin (UFH) therapy: which Anti-Factor Xa assay is appropriate?
    Ignjatovic V, Summerhayes R, Gan A, Than J, Chan A, Cochrane A, Bennett M, Horton S, Shann F, Lane G, Ross-Smith M, Monagle P.
    Thromb Res; 2007 Dec 07; 120(3):347-51. PubMed ID: 17118432
    [Abstract] [Full Text] [Related]

  • 16. Compliance with platelet count monitoring recommendations and management of possible heparin-induced thrombocytopenia in hospitalized patients receiving low-molecular-weight heparin.
    ten Berg MJ, van den Bemt PM, Huisman A, Schobben AF, Egberts TC, van Solinge WW.
    Ann Pharmacother; 2009 Sep 07; 43(9):1405-12. PubMed ID: 19690229
    [Abstract] [Full Text] [Related]

  • 17. Heptest-STAT, a new assay for monitoring of low-molecular-weight heparins, is not influenced by pregnancy-related changes of blood plasma.
    Dempfle CE, Zharkowa U, Elmas E, Ahmad-Nejad P, Neumaier M, Borggrefe M.
    Thromb Haemost; 2009 Nov 07; 102(5):1001-6. PubMed ID: 19888540
    [Abstract] [Full Text] [Related]

  • 18. Suppression of intimal hyperplasia with low molecular weight heparin in a sheep model.
    Ao PY, Hawthorne WJ, Coombs R, Fletcher JP.
    Int Angiol; 1999 Jun 07; 18(2):131-9. PubMed ID: 10424369
    [Abstract] [Full Text] [Related]

  • 19. Factor Xa-activated whole blood clotting time (Xa-ACT) for bedside monitoring of dalteparin anticoagulation during haemodialysis.
    Frank RD, Brandenburg VM, Lanzmich R, Floege J.
    Nephrol Dial Transplant; 2004 Jun 07; 19(6):1552-8. PubMed ID: 15034159
    [Abstract] [Full Text] [Related]

  • 20. Low molecular weight heparin and haemodialysis: neutralization by protaminchloride.
    Andrassy K.
    Blood Coagul Fibrinolysis; 1993 Dec 07; 4 Suppl 1():S39-43. PubMed ID: 8180328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.